Phibro Animal Health Corporation (PAHC) StockValueFinder Review
Phibro Animal Health Corporation is a healthcare company operating within the drug manufacturers – specialty & generic industry. This article provides an in-depth analysis of PAHC based on the metrics and scores provided by StockValueFinder, a tool designed to help investors evaluate stocks using objective criteria.
#### Why the StockValueFinder Score Matters StockValueFinder evaluates companies across several financial health indicators and assigns them a score out of 100%. A higher score indicates better overall financial health according to the system's criteria. For Phibro Animal Health Corporation, the current score is 7%, which falls into the "AVOID" rating category. This low score suggests that PAHC does not meet many of StockValueFinder’s stringent criteria for a high-quality investment.
#### EPS Strength and Consistency Earnings Per Share (EPS) strength is crucial because it reflects how efficiently a company can generate profits relative to its share count. A consistent, growing EPS over time indicates strong business performance and profitability. However, the system has marked PAHC's EPS test as "Did not pass." While specific EPS figures are not provided here, this result suggests that the company’s earnings history may be inconsistent or declining.
**Example:** If a company had an EPS of $2 in year 1 and dropped to $0.50 by year 3, it would likely fail the EPS strength test due to poor consistency and growth trends.
#### ROIC and Capital Efficiency Return on Invested Capital (ROIC) measures how effectively a firm uses its capital to generate profits. A higher ROIC indicates better use of resources and stronger profitability. Phibro Animal Health Corporation's ROIC is 8.49%, which StockValueFinder considers weak since the system prefers ROIC levels above 10%.
**Example:** If Company A has an ROIC of 15% while Company B only achieves 4%, investors would generally prefer Company A as it demonstrates superior capital efficiency and profitability.
#### Interest Coverage and Financial Safety Interest coverage measures a company's ability to meet its interest obligations with operating income. Higher ratios indicate stronger financial health. Phibro Animal Health Corporation did not pass the interest coverage test, indicating that its ratio is below StockValueFinder’s preferred threshold of 6 or higher.
**Example:** A company with an interest coverage ratio of 8x can comfortably cover its debt costs compared to a company at only 2x, which might struggle under rising interest rates.
#### Debt Payback and Balance Sheet Discipline Debt payback years indicate how long it would take for a company to repay all its debts using current earnings before interest and taxes (EBIT). A shorter period is preferable. Phibro Animal Health Corporation's debt payback years are 71.74, which StockValueFinder deems poor since the system recommends less than 3 years.
**Example:** If Company C has a debt payback of 1.5 years versus 7 years for Company D, investors would likely favor Company C due to its healthier balance sheet and lower risk profile.
#### P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio compares stock price with earnings per share, indicating valuation relative to profitability. A lower P/E suggests better value. Phibro Animal Health Corporation's P/E is 15.97, which StockValueFinder views as above its preferred threshold of 15 or less.
**Example:** If a company has a P/E ratio of 8 compared to another at 40, the first would generally be considered more undervalued and potentially attractive for investment.
#### Moving Average Trend and Entry Timing The moving average trend signal evaluates short-term price movement trends. Phibro Animal Health Corporation’s current signal is "WEAK TREND," indicating that recent prices have been declining relative to longer-term averages. The entry signal, however, remains "N/A" as no specific buy or sell timing has been recommended.
**Example:** If a stock's moving average trend shows an upward trajectory while the P/E ratio suggests undervaluation, it might be considered a good time for entry according to StockValueFinder’s criteria.
#### Overall Financial Strengths and Weaknesses
Based on the metrics provided by StockValueFinder
– **Weaknesses:** PAHC fails in EPS strength, ROIC, interest coverage, debt payback years, and P/E ratio valuation tests. These factors suggest poor financial health, high risk of default, inefficient capital use, and overvaluation relative to earnings. – **Strengths:** No specific strengths are highlighted by the current data provided.
#### Risks and Limitations Investing in Phibro Animal Health Corporation involves significant risks given its low StockValueFinder score. The company’s financial metrics indicate potential issues with profitability, debt management, and valuation discipline. Investors should be cautious and consider these factors before making any investment decisions.
#### Educational Conclusion This review highlights the importance of thorough financial analysis when considering stock investments. Metrics such as EPS strength, ROIC, interest coverage, debt payback years, P/E ratio, and moving average trends provide critical insights into a company’s financial health and valuation. For Phibro Animal Health Corporation, these metrics suggest areas for concern rather than confidence.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
Specializing in monetary economics, market incentives, and investment risk.